Credit: Nair, et al. (2024). A novel artificial intelligence–powered tool for precise risk stratification of prostate cancer progression in patients with clinical intermediate risk. European Urology https://doi.org/10.1016/j.eururo.2024.07.013
The figure provides a schematic overview of the Pathomiq_PRAD AI pipeline, including the pre-processing steps and deep learning algorithms used for morphology quantification and risk-score prediction.